Article
PBP 2a mutations producing very-high-level resistance to beta-lactams.
Antimicrobial agents and chemotherapy - 1 Feb 2004
Katayama Yuki, Zhang Hong-Zhong, Chambers Henry F
Abstract excerpt
Resistance to the beta-lactam class of antibiotics in methicillin-resistant Staphylococcus aureus (MRSA) is mediated by PBP 2a, a synthetic bacterial cell wall penicillin-binding protein with a low affinity of binding to beta-lactams that is encoded by mecA. Beta-lactams that bind to PBP 2a with a high affinity and that are highly active against MRSA are under development. The potential for the emergence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
